13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001762304
Total reported value
$832.1M
$832.1M
45 檔
218.8%
During the Q4 2024 filing period, Hhlr Advisors, LTD. (CIK: 0001762304) submitted its Form 13F report to the U.S. SEC, disclosing a tracked public equity portfolio valued at $832.1M across 45 reported positions.
Hhlr Advisors, LTD. executed strategic sector rebalancing during Q4 2024, establishing 5 new positions while fully exiting 8 holdings and trimming 10 positions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ONC | Beone Medicines Ltd-adr | Stock-Other | 24.34% | -18.36% | EXIT | |
| 2 | BABA | Alibaba Group Holding-sp Adr | Stock-Consumer Disc | 14.35% | -16.28% | -44.64% | |
| 3 | PDD | Pdd Holdings Inc | Stock-Consumer Disc | 9.17% | -20.86% | -42.72% | |
| 4 | NTES | Netease Inc-adr | Stock-Comm Services | 8.00% | +0.54% | NEW | |
| 5 | BEKE | Ke Holdings Inc-adr | Stock-Other | 7.18% | +0.08% | +3.61% | |
| 6 | VIPS | Vipshop Holdings LTD - Adr | Stock-Consumer Disc | 6.94% | +5.41% | -5.35% | |
| 7 | LEGN | Legend Biotech Corp-adr | Stock-Other | 6.74% | +14.30% | -9.82% | |
| 8 | AVBP | Arrivent Biopharma Inc | Stock-Other | 4.14% | +10.98% | — | |
| 9 | FUTU | Futu Holdings Ltd-adr | Stock-Financials | 3.10% | +8.32% | +6.39% | |
| 10 | ✓ | Wns Holdings LTD | Stock-Other | 2.51% | — | — | |
| 11 | TCOM | Trip.com Group Ltd-adr | Stock-Consumer Disc | 2.17% | — | -48.50% | |
| 12 | JD | Jd.com Inc-adr | Stock-Consumer Disc | 2.03% | — | +5.63% | |
| 13 | ✓ | Enfusion Inc - Class A | Stock-Other | 1.77% | — | — | |
| 14 | CTKB | Cytek Biosciences Inc | Stock-Other | 1.50% | +1.80% | — | |
| 15 | KNSA | Kiniksa Pharmaceuticals International, plc | Stock-Other | 1.08% | — | — | |
| 16 | BBIO | Bridgebio Pharma Inc | Stock-Healthcare | 0.97% | — | — | |
| 17 | YSG | Yatsen Holding Ltd-adr | Stock-Other | 0.95% | +0.96% | -1.46% | |
| 18 | CTNM | Contineum Therapeutics Inc-a | Stock-Other | 0.34% | +0.80% | — | |
| 19 | API | Agora Inc-adr | Stock-Other | 0.30% | +0.57% | — | |
| 20 | ZTO | Zto Express Cayman Inc-adr | Stock-Other | 0.30% | — | -85.48% | |
| 21 | TSM | Taiwan Semiconductor-sp Adr | Stock-Tech | 0.29% | +0.58% | +119.58% | |
| 22 | SOHU | Sohu.com Ltd-adr | Stock-Other | 0.23% | — | -28.44% | |
| 23 | NBP | Novabridge Biosciences | Stock-Other | 0.18% | +0.52% | -13.44% | |
| 24 | GOSS | Gossamer Bio Inc | Stock-Other | 0.16% | — | — | |
| 25 | SGMT | Sagimet Biosciences Inc-a | Stock-Other | 0.11% | +0.44% | — | |
| 26 | ALGS | Aligos Therapeutics Inc | Stock-Other | 0.11% | +0.02% | — | |
| 27 | DHR | Danaher CORP | Stock-Healthcare | 0.10% | — | +43.66% | |
| 28 | MGX | Metagenomi Therapeutics Inc | Stock-Other | 0.10% | — | — | |
| 29 | TUYA | Tuya Inc | Stock-Other | 0.10% | +0.11% | — | |
| 30 | EM | Smart Share Global LTD - Adr | Stock-Other | 0.10% | — | — | |
| 31 | GEV | GE Vernova Inc | Stock-Industrials | 0.09% | — | +1.03% | |
| 32 | MSCI | Msci Inc | Stock-Financials | 0.08% | — | — | |
| 33 | MCO | Moody's CORP | Stock-Financials | 0.07% | — | +198.07% | |
| 34 | MOGU | Mogu Inc-adr | Stock-Other | 0.06% | +0.06% | — | |
| 35 | GE | General Electric | Stock-Industrials | 0.06% | +0.28% | +80.78% | |
| 36 | BEDU | Bright Scholar Education-adr | Stock-Other | 0.06% | — | — | |
| 37 | PACB | Pacific Biosciences Of Calif | Stock-Other | 0.06% | +0.12% | — | |
| 38 | JOYY | Joyy Inc-adr | Stock-Other | 0.04% | — | — | |
| 39 | TT | Trane Technologies plc | Stock-Industrials | 0.03% | — | +210.49% | |
| 40 | D0A | Dada Nexus Ltd-adr | Stock-Other | 0.03% | — | +16.67% | |
| 41 | PYXS | Pyxis Oncology Inc | Stock-Other | 0.02% | — | — | |
| 42 | MOMO | Hello Group Inc -spn Adr | Stock-Other | 0.01% | — | — | |
| 43 | ✓ | Stock-Other | 0.01% | — | — | ||
| 44 | UXIN | Uxin LTD - Adr | Stock-Other | — | — | EXIT | |
| 45 | ✓ | Stock-Other | — | — | EXIT |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | NTES | Netease Inc-adr | +2.7% | — | Unchanged |
| 2 | ✓ | Wns Holdings LTD | +2.5% | NEW | New buy |
| 3 | BEKE | Ke Holdings Inc-adr | +2.4% | +3.61% | Add |
| 4 | AVBP | Arrivent Biopharma Inc | +1.8% | — | Unchanged |
| 5 | VIPS | Vipshop Holdings LTD - Adr | +1.5% | -5.35% | Trim |
| 6 | FUTU | Futu Holdings Ltd-adr | +0.9% | +6.39% | Add |
| 7 | ✓ | Enfusion Inc - Class A | +0.7% | — | Unchanged |
| 8 | CTKB | Cytek Biosciences Inc | +0.7% | — | Unchanged |
| 9 | JD | Jd.com Inc-adr | +0.6% | +5.63% | Add |
| 10 | YSG | Yatsen Holding Ltd-adr | +0.4% | -1.46% | Trim |
| 11 | BBIO | Bridgebio Pharma Inc | +0.4% | — | Unchanged |
| 12 | API | Agora Inc-adr | +0.3% | NEW | New buy |
| 13 | TSM | Taiwan Semiconductor-sp Adr | +0.2% | +119.58% | Add |
| 14 | KNSA | Kiniksa Pharmaceuticals International, plc | +0.2% | — | Unchanged |
| 15 | ALGS | Aligos Therapeutics Inc | +0.1% | — | Unchanged |
| 16 | MSCI | Msci Inc | +0.1% | NEW | New buy |
| 17 | SGMT | Sagimet Biosciences Inc-a | +0.1% | — | Unchanged |
| 18 | CTNM | Contineum Therapeutics Inc-a | +0.1% | — | Unchanged |
| 19 | MGX | Metagenomi Therapeutics Inc | +0.1% | — | Unchanged |
| 20 | MCO | Moody's CORP | +0.1% | +198.07% | Add |
| 21 | GEV | GE Vernova Inc | +0.1% | +1.03% | Add |
| 22 | GOSS | Gossamer Bio Inc | +0.1% | — | Unchanged |
| 23 | GE | General Electric | 0% | +80.78% | Add |
| 24 | DHR | Danaher CORP | 0% | +43.66% | Add |
| 25 | TUYA | Tuya Inc | 0% | — | Unchanged |
| 26 | EM | Smart Share Global LTD - Adr | 0% | — | Unchanged |
| 27 | PACB | Pacific Biosciences Of Calif | 0% | — | Unchanged |
| 28 | TT | Trane Technologies plc | 0% | +210.49% | Add |
| 29 | BEDU | Bright Scholar Education-adr | 0% | — | Unchanged |
| 30 | JOYY | Joyy Inc-adr | 0% | — | Unchanged |
| 31 | MOMO | Hello Group Inc -spn Adr | 0% | NEW | New buy |
| 32 | MOGU | Mogu Inc-adr | 0% | — | Unchanged |
| 33 | D0A | Dada Nexus Ltd-adr | 0% | +16.67% | Add |
| 34 | ✓ | 0% | NEW | New buy | |
| 35 | UXIN | Uxin LTD - Adr | — | — | Unchanged |
| 36 | ✓ | — | — | Unchanged | |
| 37 | NBP | Novabridge Biosciences | 0% | -13.44% | Trim |
| 38 | PYXS | Pyxis Oncology Inc | 0% | — | Unchanged |
| 39 | ✓ | 0% | EXIT | Sold out | |
| 40 | SOHU | Sohu.com Ltd-adr | 0% | -28.44% | Trim |
| 41 | META | Meta Platforms Inc-class A | -0.1% | EXIT | Sold out |
| 42 | URA | Global X Uranium ETF | -0.1% | EXIT | Sold out |
| 43 | KWEB | Kranesh Csi China Internet | -0.1% | EXIT | Sold out |
| 44 | ZKN | Zeekr Intelligent Techno-adr | -0.1% | EXIT | Sold out |
| 45 | TCOM | Trip.com Group Ltd-adr | -0.2% | -48.50% | Trim |
| 46 | LEGN | Legend Biotech Corp-adr | -0.4% | -9.82% | Trim |
| 47 | HTHT | H World Group Ltd-adr | -0.5% | EXIT | Sold out |
| 48 | YUMC | Yum China Holdings Inc | -0.7% | EXIT | Sold out |
| 49 | BIDU | Baidu Inc - Spon Adr | -0.7% | EXIT | Sold out |
| 50 | ONC | Beone Medicines Ltd-adr | -1.2% | -26.51% | Trim |
According to official SEC Form 13F filings, Hhlr Advisors, LTD. reported a total U.S. public equity portfolio value of $832.1M across 45 disclosed positions in Q4 2024.
During Q4 2024, Hhlr Advisors, LTD.'s top holdings by market value included ONC (24.3%)、BABA (14.3%)、PDD (9.2%). The largest single position, ONC, represented 24.3% of total portfolio value.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including ONC, BABA, PDD) accounted for 218.8% of total reported equity market value during Q4 2024.
Top New Position Initiated
WNS HOLDINGS LTD
市值: $72.6M
Top Position Liquidated / Trimmed
BIDU
前期市值: $31.6M
In Q4 2024, Hhlr Advisors, LTD. made 33 total portfolio adjustments, initiating 5 new buys, adding to 10 positions, trimming 10 holdings, and fully liquidating 8 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.